Spatial single-cell profiling reveals macrophage niches in severe COVID-19 lungs

Spatial single-cell profiling reveals macrophage niches in severe COVID-19 lungs

Joan Abinet
1,2,*,#
,
Cecilia Ruscitti
1,2,*,#
,
Mutien Garigliany
2,3
,
Maude Liégeois
1,2
,
Coraline Radermecker
1,2,†
,
Thomas Marichal
1,2,4,†
*Correspondence to: Joan Abinet, Laboratory of Immunophysiology, GIGA Institute, University of Liège, Liège 4000, Belgium; Faculty of Veterinary Medicine, University of Liège, Liège 4000, Belgium. E-mail: Joan.Abinet@uliege.be
Cecilia Ruscitti, Laboratory of Immunophysiology, GIGA Institute, University of Liège, Liège 4000, Belgium; Faculty of Veterinary Medicine, University of Liège, Liège 4000, Belgium. E-mail: Cecilia.Ruscitti@uliege.be
Myeloid Cells. 2026;1:202612. 10.70401/mc.2026.0014
Received: May 26, 2026Accepted: September 14, 2026Published: September 15, 2026
Tips Icon
This manuscript is made available in its unedited form to allow early access to the reported findings. Further editing will be completed before final publication. As such, the content may include errors, and standard legal disclaimers are applicable.

Abstract

Aims: Severe COVID-19 is characterized by marked heterogeneity in lung pathology, including diffuse alveolar damage, inflammation, and fibrosis. However, how spatially organized cellular interactions contribute to these divergent pathological outcomes remains incompletely understood. We aimed to define the spatial organization of cellular microenvironments in severe COVID-19 lungs and identify niche-specific cellular interactions associated with distinct histopathological states.

Methods: We applied imaging-based single-cell spatial transcriptomics to post-mortem lung tissues from patients with severe COVID-19 and control subjects, enabling high-resolution mapping of cellular composition, spatial neighborhoods, and predicted ligand-receptor interactions within intact tissue architecture.

Results: Analysis of 76,973 cells identified 20 distinct cell populations and revealed marked heterogeneity between COVID-19 samples, corresponding to different histopathological states. Spatial niche analysis identified discrete macrophage-associated microenvironments. Fibrotic niches were enriched in CHI3L1/MMP9hi macrophages spatially associated with COL1A1+ fibroblasts and basal cells. Ligand-receptor inference predicted macrophage-derived TGF-β and galectin-3 signaling as drivers of pathogenic fibroblast activation and extracellular matrix remodeling. In contrast, alveolar niches contained SPP1hi macrophages exposed to epithelial-derived cues, including WNT ligands and GM-CSF, consistent with differentiation toward an alveolar macrophage-like state.

Conclusion: Severe COVID-19 lungs are organized into distinct spatial niches associated with divergent immunopathological trajectories. Imaging-based spatial transcriptomics provides a framework to link histopathological states with localized cellular interactions and macrophage-driven tissue remodeling programs.

Keywords

Macrophage, single-cell spatial transcriptomics, COVID-19

References

  • 1. World Health Organization. COVID-19 cases|WHO COVID-19 dashboard [Internet]. Geneva: World Health Organization; 2023. Available from: https://data.who.int/dashboards/covid19/cases
  • 2. Del Sole F, Farcomeni A, Loffredo L, Carnevale R, Menichelli D, Vicario T, et al. Features of severe COVID-19: A systematic review and meta-analysis. Eur J Clin Invest. 2020;50(10):e13378.
    [DOI] [PubMed] [PMC]
  • 3. Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: A global literature survey. Crit Care. 2020;24(1):516.
    [DOI]
  • 4. Azagew AW, Beko ZW, Ferede YM, Mekonnen HS, Abate HK, Mekonnen CK. Global prevalence of COVID-19-induced acute respiratory distress syndrome: Systematic review and meta-analysis. Syst Rev. 2023;12(1):212.
    [DOI]
  • 5. Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA, Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: Pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev. 2021;30(162):210194.
    [DOI] [PubMed] [PMC]
  • 6. Milross L, Hunter B, McDonald D, Merces G, Thomson A, Hilkens CMU, et al. Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19. EBioMedicine. 2024;99:104945.
    [DOI]
  • 7. Ashwin H, Milross L, Wilson J, Majo J, Hang Lee JT, Calder G, et al. Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients. J Clin Pathol. 2023;76(8):561-565.
    [DOI] [PubMed] [PMC]
  • 8. Cardinal-Fernández P, Lorente JA, Ballén-Barragán A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Ann Am Thorac Soc. 2017;14(6):844-850.
    [DOI] [PubMed]
  • 9. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77(2):198-209.
    [DOI]
  • 10. Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135-1140.
    [DOI] [PubMed] [PMC]
  • 11. Lee JTH, Barnett SN, Roberts K, Ashwin H, Milross L, Cho JW, et al. Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19. Nat Commun. 2025;16(1):1979.
    [DOI] [PubMed] [PMC]
  • 12. Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021;593(7860):564-569.
    [DOI]
  • 13. Rovito R, Augello M, Ben-Haim A, Bono V, d’Arminio Monforte A, Marchetti G. Hallmarks of severe COVID-19 pathogenesis: A pas de deux between viral and host factors. Front Immunol. 2022;13:912336.
    [DOI] [PubMed] [PMC]
  • 14. Ganesan A, Moore AR, Zheng H, Toh J, Freedman M, Magis AT, et al. A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response. Immunity. 2025;58(8):2104-2119.e5.
    [DOI]
  • 15. Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, d’Emal C, et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020;217(12):e20201012.
    [DOI] [PubMed] [PMC]
  • 16. Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, et al. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med. 2021;2(1):100166.
    [DOI] [PubMed] [PMC]
  • 17. Xu G, Qi F, Wang H, Liu Y, Wang X, Zou R, et al. The transient IFN response and the delay of adaptive immunity feature the severity of COVID-19. Front Immunol. 2021;12:816745.
    [DOI] [PubMed] [PMC]
  • 18. MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, et al. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021;6(13):e147413.
    [DOI]
  • 19. Chen ST, Park MD, del Valle DM, Buckup M, Tabachnikova A, Thompson RC, et al. A shift in lung macrophage composition is associated with COVID-19 severity and recovery. Sci Transl Med. 2022;14(662):eabn5168.
    [DOI] [PubMed] [PMC]
  • 20. Krausgruber T, Fortelny N, Fife-Gernedl V, Senekowitsch M, Schuster LC, Lercher A, et al. Structural cells are key regulators of organ-specific immune responses. Nature. 2020;583(7815):296-302.
    [DOI] [PubMed] [PMC]
  • 21. Wendisch D, Dietrich O, Mari T, von Stillfried S, Ibarra IL, Mittermaier M, et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell. 2021;184(26):6243-6261.e27.
    [DOI] [PubMed] [PMC]
  • 22. Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970-979.
    [DOI]
  • 23. Margaroli C, Benson P, Sharma NS, Madison MC, Robison SW, Arora N, et al. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures. Cell Rep Med. 2021;2(4):100242.
    [DOI] [PubMed] [PMC]
  • 24. Fennell É, Taylor GS, Leahy CI, Ross AM, Reynolds G, Perry T, et al. Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19. Eur Respir J. 2025;66(3):2301699.
    [DOI] [PubMed] [PMC]
  • 25. He S, Bhatt R, Brown C, Brown EA, Buhr DL, Chantranuvatana K, et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat Biotechnol. 2022;40(12):1794-1806.
    [DOI] [PubMed]
  • 26. Rizzoli E, de Meeûs d’Argenteuil C, Fastrès A, Roels E, Janssen P, Puré E, et al. Fibroblast activation protein is a cellular marker of fibrotic activity in canine idiopathic pulmonary fibrosis. Front Vet Sci. 2024;11:1416124.
    [DOI] [PubMed] [PMC]
  • 27. Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42(2):293-304.
    [DOI] [PubMed] [PMC]
  • 28. Han Y, Leng D, Zhang T, Ge J, Fang Y, Lu T, et al. A human immuno-lung organoid model to study macrophage-mediated lung cell senescence upon SARS-CoV-2 infection. Adv Sci. 2025;12(36):e03932.
    [DOI] [PubMed] [PMC]
  • 29. Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2022;40(4):517-526.
    [DOI] [PubMed] [PMC]
  • 30. Sikkema L, Ramírez-Suástegui C, Strobl DC, Gillett TE, Zappia L, Madissoon E, et al. An integrated cell atlas of the lung in health and disease. Nat Med. 2023;29(6):1563-1577.
    [DOI] [PubMed] [PMC]
  • 31. Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292-3320.
    [DOI]
  • 32. Gu Z. Complex heatmap visualization. IMeta. 2022;1(3):e43.
    [DOI]
  • 33. Browaeys R, Saelens W, Saeys Y. NicheNet: Modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159-162.
    [DOI]
  • 34. Chen JG, Chávez-Fuentes JC, O’Brien M, Xu J, Ruiz EC, Wang W, et al. Giotto Suite: A multiscale and technology-agnostic spatial multiomics analysis ecosystem. Nat Methods. 2025;22(10):2052-2064.
    [DOI] [PubMed] [PMC]
  • 35. Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, Suzuki H, et al. Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med. 1999;189(9):1497-1506.
    [DOI] [PubMed] [PMC]
  • 36. Chakarov S, Lim HY, Tan L, Lim SY, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363(6432):eaau0964.
    [DOI] [PubMed]
  • 37. Vanneste D, Bai Q, Hasan S, Peng W, Pirottin D, Schyns J, et al. MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation. Nat Immunol. 2023;24(5):827-840.
    [DOI] [PubMed] [PMC]
  • 38. Wu CT, Lidsky PV, Xiao Y, Cheng R, Lee IT, Nakayama T, et al. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell. 2023;186(1):112-130.e20.
    [DOI] [PubMed] [PMC]
  • 39. Dodd DO, Mechaussier S, Yeyati PL, McPhie F, Anderson JR, Khoo CJ, et al. Ciliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules. Science. 2024;384(6694):eadf5489.
    [DOI] [PubMed] [PMC]
  • 40. Umekita K, Miyauchi S, Nomura H, Umeki K, Okayama A. Neutrophil-derived lactoferrin induces the inflammatory responses of rheumatoid arthritis synovial fibroblasts via Toll-like receptor 4. Clin Exp Rheumatol. 2019;37(5):834-841.
    [PubMed]
  • 41. Sprenkeler EGG, Zandstra J, van Kleef ND, Goetschalckx I, Verstegen B, Aarts CEM, et al. S100A8/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation. Cells. 2022;11(2):236.
    [DOI] [PubMed] [PMC]
  • 42. Desai N, Neyaz A, Szabolcs A, Shih AR, Chen JH, Thapar V, et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun. 2020;11(1):6319.
    [DOI]
  • 43. Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions. Cell Rep Med. 2021;2(5):100287.
    [DOI] [PubMed] [PMC]
  • 44. Hoyne GF, Elliott H, Mutsaers SE, Prêle CM. Idiopathic pulmonary fibrosis and a role for autoimmunity. Immunol Cell Biol. 2017;95(7):577-583.
    [DOI] [PubMed]
  • 45. Tsukui T, Sun KH, Wetter JB, Wilson-Kanamori JR, Hazelwood LA, Henderson NC, et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun. 2020;11(1):1920.
    [DOI] [PubMed] [PMC]
  • 46. Wu X, Zhang D, Qiao X, Zhang L, Cai X, Ji J, et al. Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis. Eur Respir J. 2023;61(6):2201799.
    [DOI] [PubMed] [PMC]
  • 47. Tsukui T, Wolters PJ, Sheppard D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature. 2024;631(8021):627-634.
    [DOI] [PubMed] [PMC]
  • 48. Bergantini L, Mainardi A, D’Alessandro M, Cameli P, Bennett D, Bargagli E, et al. Common molecular pathways between post-COVID19 syndrome and lung fibrosis: A scoping review. Front Pharmacol. 2022;13:748931.
    [DOI] [PubMed] [PMC]
  • 49. Choi EY, Park HH, Kim H, Kim HN, Kim I, Jeon S, et al. Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients. Eur Respir J. 2020;56(5):2001531.
    [DOI] [PubMed] [PMC]
  • 50. Zhu B, Wu Y, Huang S, Zhang R, Son YM, Li C, et al. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity. 2021;54(6):1200-1218.e9.
    [DOI]
  • 51. Sehgal A, Irvine KM, Hume DA. Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair. Semin Immunol. 2021;54:101509.
    [DOI] [PubMed]
  • 52. Gschwend J, Sherman SPM, Ridder F, Feng X, Liang HE, Locksley RM, et al. Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth. J Exp Med. 2021;218(10):e20210745.
    [DOI] [PubMed] [PMC]
  • 53. Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe Å, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595(7865):107-113.
    [DOI] [PubMed] [PMC]
  • 54. Vannan A, Lyu R, Williams AL, Negretti NM, Mee ED, Hirsh J, et al. Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis. Nat Genet. 2025;57(3):647-658.
    [DOI]
  • 55. Ruscitti C, Abinet J, Maréchal P, Meunier M, de Meeûs C, Vanneste D, et al. Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury. Sci Immunol. 2024;9(98):eado1227.
    [DOI]
  • 56. Cong B, Dong X, Yang Z, Yu P, Chai Y, Liu J, et al. Single-cell spatiotemporal analysis of the lungs reveals Slamf9+ macrophages involved in viral clearance and inflammation resolution. Cell Discov. 2024;10:104.
    [DOI]

© The Author(s) 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Publisher’s Note

Science Exploration remains a neutral stance on jurisdictional claims in published maps and institutional affiliations. The views expressed in this article are solely those of the author(s) and do not reflect the opinions of the Editors or the publisher.

Share And Cite

Science Exploration Style
Abinet J, Ruscitti C, Garigliany M, Liégeois M, Radermecker C, Marichal T. Spatial single-cell profiling reveals macrophage niches in severe COVID-19 lungs. Myeloid Cells. 2026;1:202612. https://doi.org/10.70401/mc.2026.0014

Submit a Manuscript
Author Instructions
Cite this Article
Export Citation
Article Metrics
0
View
0
Download
Cited
Article Updates
Citation Icon Get citation